JEPAX
Price
$14.08
Change
-$0.01 (-0.07%)
Updated
Jul 13 closing price
Net Assets
5.06B
PMYRX
Price
$13.14
Change
-$0.01 (-0.08%)
Updated
Jul 13 closing price
Net Assets
166.51M
Interact to see
Advertisement

JEPAX vs PMYRX

JEPAX vs PMYRX Comparison Chart in %
View a ticker or compare two or three
VS
JEPAX vs. PMYRX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEPAX is a Buy and PMYRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JEPAX has more cash in the bank: 5.07B vs. PMYRX (167M). PMYRX pays higher dividends than JEPAX: PMYRX (10.59) vs JEPAX (7.78). JEPAX was incepted earlier than PMYRX: JEPAX (8 years) vs PMYRX (16 years). PMYRX (1.07) is less costly to investors than JEPAX (0.84). JEPAX is a more actively managed with annual turnover of: 176.00 vs. PMYRX (65.00). JEPAX has a lower initial minimum investment than PMYRX: JEPAX (1000) vs PMYRX (1000000). PMYRX annual gain was more profitable for investors over the last year : 14.02 vs. JEPAX (7.93). JEPAX return over 5 years is better than : 39.81 vs. PMYRX (23.52).
JEPAXPMYRXJEPAX / PMYRX
Total Expense Ratio0.840.9093%
Annual Report Gross Expense Ratio0.841.0779%
Fund Existence8 years16 years-
Gain YTD2.9427.06142%
Front Load5%N/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets5.07B167M3,033%
Annual Yield % from dividends7.7810.5974%
Returns for 1 year7.9314.0257%
Returns for 3 years28.4241.8568%
Returns for 5 years39.8123.52169%
Returns for 10 yearsN/A58.69-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLD234.145.72
+2.50%
Steel Dynamics
IPHA1.79N/A
+0.28%
Innate Pharma SA
PJT157.130.21
+0.13%
PJT Partners
INMD15.15-0.13
-0.85%
InMode Ltd
KPRX2.46-0.05
-1.99%
Kiora Pharmaceuticals Inc.